These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12351761)

  • 1. AIDS research. Mystery anti-HIV factor unmasked?
    Cohen J
    Science; 2002 Sep; 297(5590):2188. PubMed ID: 12351761
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.
    Zhang L; Yu W; He T; Yu J; Caffrey RE; Dalmasso EA; Fu S; Pham T; Mei J; Ho JJ; Zhang W; Lopez P; Ho DD
    Science; 2002 Nov; 298(5595):995-1000. PubMed ID: 12351674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. Versatile defensins.
    Ganz T
    Science; 2002 Nov; 298(5595):977-9. PubMed ID: 12411693
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new veil removed from the physiologic mysteries of "HIV control" ].
    Nau JY
    Rev Med Suisse; 2007 Apr; 3(107):1017. PubMed ID: 17526378
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.
    Ahmed RK; Norrgren H; da Silva Z; Blaxhult A; Fredriksson EL; Biberfeld G; Andersson S; Thorstensson R
    Scand J Immunol; 2005 Jan; 61(1):63-71. PubMed ID: 15644124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The innate cellular responses to HIV-1 invasion: emerging molecules of ancient defense mechanisms.
    Simm M
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):131-8. PubMed ID: 17557144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristic CD8+ T cell response in HIV controllers: an objective to achieve?
    Sáez-Cirión A
    Pathol Biol (Paris); 2008 Jul; 56(5):251-3. PubMed ID: 18178027
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M
    Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.
    Chang TL; François F; Mosoian A; Klotman ME
    J Virol; 2003 Jun; 77(12):6777-84. PubMed ID: 12767998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1973-6. PubMed ID: 15730808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1-specific CD8(+) T cells do not correlate with viral load in HIV-1-positive patients.
    Bartovská Z; Beran O; Rozsypal H; Holub M
    Acta Virol; 2007; 51(1):59-61. PubMed ID: 17432946
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of IL-16 in HIV replication.
    Mackewicz CE; Levy JA; Cruikshank WW; Kornfeld H; Center DM
    Nature; 1996 Oct; 383(6600):488-9. PubMed ID: 8849720
    [No Abstract]   [Full Text] [Related]  

  • 13. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells in HIV-1 infection: role of NK cell-mediated non-cytolytic mechanisms in pathogenesis of HIV-1 infection.
    Kottilil S
    Indian J Exp Biol; 2003 Nov; 41(11):1219-25. PubMed ID: 15332487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 and its ligands: a new axis of evil?
    Lederman MM; Sieg SF
    Nat Immunol; 2007 Dec; 8(12):1283-5. PubMed ID: 18026077
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of beta-chemokines in suppressing HIV replication.
    Mackewicz CE; Barker E; Levy JA
    Science; 1996 Nov; 274(5291):1393-5. PubMed ID: 8966605
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
    Bronke C; Westerlaken GH; Miedema F; Tesselaar K; van Baarle D
    Immunol Lett; 2005 Mar; 97(2):215-24. PubMed ID: 15752561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV suppressors found in cells.
    Smart T
    GMHC Treat Issues; 1996 Jan; 10(1):10-2. PubMed ID: 11363373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.